FALSELY ELEVATED SERUM DIGOXIN LEVELS SECONDARY TO ENDOGENOUS DIGOXIN-LIKE IMMUNOREACTIVE SUBSTANCES

被引：6

作者：

KOOBATIAN, TJ

ROBERTS, JR

机构：

[1] MISERICORDIA HOSP,MERCY CATHOLIC MED CTR,DEPT EMERGENCY MED,DIV TOXICOL,PHILADELPHIA,PA 19143

[2] MED COLL PENN,DEPT EMERGENCY MED,DIV TOXICOL,PHILADELPHIA,PA

来源：

ACADEMIC EMERGENCY MEDICINE | 1995年 / 2卷 / 04期

关键词：

DIGOXIN; ASSAY; IMMUNOREACTIVE SUBSTANCES; POISONING; OVERDOSE; TOXICOLOGY;

D O I：

10.1111/j.1553-2712.1995.tb03231.x

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

Endogenous digoxin-like immunoreactive substances (DLIS) are produced by the human body and can be significantly elevated in specific clinical conditions. Commercially available digoxin assays do not have the specificity to fully distinguish DLIS from exogenous digoxin, though DLIS do not possess the same therapeutic properties as do the drug. The resultant artificial elevation of a reported digoxin level or a completely factitious level in a patient not taking the drug can have clinically significant consequences.

引用

页码：322 / 326

页数：5

共 50 条

[21] ENDOGENOUS DIGOXIN-LIKE IMMUNOREACTIVE FACTORS - IMPACT ON DIGOXIN MEASUREMENTS AND POTENTIAL PHYSIOLOGICAL IMPLICATIONS
VALDES, R
CLINICAL CHEMISTRY, 1985, 31 (09) : 1525 - 1532
[22] ENDOGENOUS DIGOXIN-LIKE IMMUNOREACTIVE SUBSTANCES ELIMINATED FROM SERUM SAMPLES FROM PATIENTS WITH LIVER-DISEASE BY THE EMIT COLUMN DIGOXIN ASSAY
KULAOTS, IA
PUDEK, MR
SECCOMBE, DW
CLINICAL CHEMISTRY, 1987, 33 (08) : 1490 - 1491
[23] DIGOXIN-LIKE IMMUNOREACTIVE SUBSTANCES IN CHRONIC LIVER-DISEASE
YANG, SS
KORULA, J
SUNDHEIMER, JE
KEYSER, AJ
HEPATOLOGY, 1989, 9 (03) : 363 - 366
[24] Interference of endogenous digoxin-like immunoreactive factors in serum digoxin measurement is minimized in a new turbidimetric digoxin immunoassay on ADVIA 1650 analyzer
Datta, P
Dasgupta, A
THERAPEUTIC DRUG MONITORING, 2004, 26 (01) : 85 - 89
[25] EFFECT OF AGE AND SERUM CREATININE ON ENDOGENOUS DIGOXIN-LIKE SUBSTANCES IN INFANTS AND CHILDREN
PHELPS, SJ
KAMPER, CA
BOTTORFF, MB
ALPERT, BS
JOURNAL OF PEDIATRICS, 1987, 110 (01): : 136 - 139
[26] SPECIFIC INTERACTION BETWEEN ANTIDIGOXIN ANTIBODIES AND DIGOXIN-LIKE IMMUNOREACTIVE SUBSTANCES IN CORD SERUM
SCHERRMANN, JM
SANDOUK, P
GUEDENEY, X
CLINICAL CHEMISTRY, 1986, 32 (01) : 97 - 100
[27] INTERFERENCE OF DIGOXIN-LIKE IMMUNOREACTIVE SUBSTANCES WITH TDX DIGOXIN-II ASSAY IN DIFFERENT PATIENTS
AVENDANO, C
ALVAREZ, JS
SACRISTAN, JA
ADIN, J
ALSAR, MJ
THERAPEUTIC DRUG MONITORING, 1991, 13 (06) : 523 - 527
[28] ENDOGENOUS DIGOXIN-LIKE FACTORS
HADDY, FJ
ISI ATLAS OF SCIENCE-PHARMACOLOGY, 1987, 1 (02): : 119 - 123
[29] MINIMIZING ANALYTICAL INTERFERENCES FROM DIGOXIN-LIKE IMMUNOREACTIVE SUBSTANCES (DLIS) IN CASES OF DIGOXIN TOXICITY
SECCOMBE, DW
PUDEK, MR
HUMPHRIES, KH
JOURNAL OF FORENSIC SCIENCES, 1987, 32 (03) : 650 - 657
[30] ENDOGENOUS DIGOXIN-LIKE IMMUNOREACTIVE FACTORS (DLIF) - IMPACT ON THE RESULTS OF 2 HOMOGENEOUS IMMUNOASSAYS FOR DIGOXIN
SCHLEBUSCH, H
FRESENIUS JOURNAL OF ANALYTICAL CHEMISTRY, 1992, 343 (01): : 113 - 114

← 1 2 3 4 5 →